High BMI at time of diagnosis has no effect on clinical outcomes for HER2-positive breast cancer
Dion Smyth Lecturer-practitioner, Cancer and palliative care, Birmingham City University
In contrast with previous findings, a retrospective cohort study carried out in Italy has found no negative effect of body mass index (BMI) at the time of diagnosis on clinical outcomes for patients with HER2-positive metastatic breast cancer.
Cancer Nursing Practice.
17, 2, 12-12.
doi: 10.7748/cnp.17.2.12.s10
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Alternatively, you can purchase access to this article for the next seven days.
Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
